What Innoprot does

Innoprot (legally Innovative Technologies In Biological Systems SL) is a privately held Spanish biotechnology supplier founded in 2007 and headquartered at the Bizkaia Technology Park in Derio, Spain. The company develops, produces, and markets cell-based assay products and related services for pharmaceutical and biotechnology drug discovery applications. Its product portfolio is organized into three pillars: cell lines (GPCR cell lines including HiTSeeker label-free lines, Nomad biosensor lines, and Internalization lines, plus stable and fluorescent cell lines), primary cells (177+ human and animal tissue-specific products across 27 tissue systems), and cell culture media and reagents. A distinguishing technical asset is the proprietary Nomad biosensor platform, which enables simultaneous monitoring of multiple GPCR signaling pathways (cAMP, Ca2+, β-arrestin, DAG) within a single cell line.

The company sells through a direct e-commerce platform with global shipping, including temperature-controlled logistics for biological materials, and reaches customers in pharmaceutical companies, biotechnology firms, academic research institutions, and contract research organizations. Beyond catalog products, Innoprot offers fee-for-service contract research in cell immortalization, stable cell line development, knockdown cell line development, and fluorescent cell line development, allowing it to capture higher-value custom projects. Pricing for advanced engineered cell lines reaches €9,995 per unit, with simpler reagents priced between €145 and €875, indicating a tiered catalog spanning consumables to high-value research tools.

Innoprot operates as a sales-led B2B life sciences supplier with no disclosed external funding, no parent company, and no subsidiaries. It maintains a bilingual English/Spanish website, a minor partnership with Bioz for product validation citations, and minor marketing integrations with Google and Meta. No AI/ML capabilities, leadership changes, M&A activity, or funding events are documented in the available source material.

Name

Innoprot

Legal name

Innovative Technologies In Biological Systems SL

Website

https://innoprot.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Innoprot is a Spanish biotech supplier founded in 2007 that develops and sells GPCR cell lines, primary cells, and cell culture reagents, plus custom cell line development services, to pharmaceutical, biotechnology, academic, and CRO customers worldwide.

Ownership category

akta.pro rank

Product category

Cell-Based Assays & Drug Discovery Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

akta.pro secondary industry

Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)

Keywords

• Cell-based assays
• GPCR cell lines
• Primary cells
• Drug discovery reagents
• Cell culture media

Headquarters

HQ city

Derio

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales

Revenue model

1. Cell Lines and Primary Cells: Sale of GPCR cell lines, stable cell lines, fluorescent cell lines, and human/animal primary cells for drug discovery research. Products are sold as individual units with pricing varying by cell type and specification.
2. Cell Culture Products: Sale of cell culture media, reagents, kits, and related consumables for cell culture applications.
3. Contract Research Services: Fee-for-service model for cell immortalization, stable cell line development, knockdown cell line development, and fluorescent cell line development services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Innoprot manufactures and distributes cell-based assay reagents, including stably expressing GPCR cell lines (HiTSeeker, Nomad, Internalization formats), stable and fluorescent cell lines, human and animal primary cells across 27+ tissue systems, and cell culture media/reagents for drug discovery. The company also offers fee-for-service contract research including cell immortalization, custom stable cell line development, knockdown cell line development, and fluorescent cell line development for pharmaceutical and biotechnology customers.

Product overview

Innoprot is a biotechnology company specializing in cell-based assays and cell culture products for drug discovery and development. The company operates as a platform of biological reagents with a portfolio organized into three main areas: (1) Cell Lines including GPCR Cell Lines (HiTSeeker, Internalization, and Nomad varieties), Stable Cell Lines, and Whole Fluorescent Cell Lines; (2) Primary Cells including Human Primary Cells (27 tissue-specific cell systems) and Animal Primary Cells; and (3) Cell Culture Media & Reagents. The company also provides contract services including Cell Immortalization, Stable Cell Line Development, Knockdown Cell Line Development, and Fluorescent Cell Line Development. Innoprot's assays are organized by target (GPCR, NHR), therapeutic area (oncology, CNS, cardiovascular, etc.), and phenotypic analysis. Products are sold directly through an e-commerce platform with pricing ranging from laboratory reagents to specialized cell lines priced up to €9,995.

Differentiator

Problem solved

Functional benefit

Brands

• HiTSeeker: Cell lines stably expressing label-free GPCRs (seven-transmembrane domain receptors) with no tag
• Nomad Cell Lines
• Internalization Cell Lines

Products and services

• GPCR Cell Lines Stably expressed GPCR cell lines including HiTSeeker (label-free), Internalization (tGFP tagged for internalization assays), and Nomad (co-expressing GPCR with biosensors for β-arrestin recruitment, Ca2+, cAMP, or DAG monitoring). Sold to pharmaceutical and biotechnology researchers for GPCR drug discovery and high-throughput screening.
• Human Primary Cells Primary cells from human tissue organized into cell systems covering 27 tissue types including cardiac, dermal, hepatic, neural, ocular, pulmonary, renal, reproductive, skeletal, and more. Sold to academic and industrial researchers for cell biology and drug discovery studies.
• Animal Primary Cells Primary cells from animal sources organized into cell systems including cardiac, dermal, hepatic, neural, ocular, pulmonary, renal, and skeletal. Used by researchers for preclinical and comparative cell biology studies.
• Stable Cell Lines Immortalized primary cells, nuclear receptor cell lines, stable cell lines for apoptosis assays, and stable cell lines for CNS research and drug screening. Sold to researchers for reproducible assay development and target validation.
• Whole Fluorescent Cell Lines Fluorescent cell lines including fluorescent immortalized primary cells, green fluorescent cell lines, red fluorescent cell lines, and TTFLUOR primary cells. Used by researchers for imaging, tracking, and high-content screening applications.
• Cell Culture Media & Reagents Cell culture reagents, cryopreservation medium, differentiation media, hypothermic storage and shipping media, low-serum media, PriGrow Medium Kits, pro-conditioned media, and serum-free media. Sold as consumables to support cell culture workflows in research laboratories.
• Cell Culture Reagents and Kits Recombinant proteins, cell adhesion reagents, subculturing reagents, and oxidative stress assay kits. Sold as consumable kits to researchers for cell-based assays and culture workflows.
• COVID-19 Related Products Airway primary cells and stable cell lines for COVID-19 research including ACE2, TMPRSS2, and SARS-CoV-2 spike protein variants. Sold to researchers conducting COVID-19 and coronavirus-related studies.
• Cell Immortalization Service Service to immortalize primary cells for extended culture while maintaining their biological characteristics. Delivered to pharmaceutical, biotechnology, and academic researchers as a fee-for-service offering.
• Stable Cell Line Development Service Custom development service for stable cell lines expressing target proteins. Delivered to drug discovery researchers requiring bespoke cell lines for specific screening or assay programs.
• Knockdown Cell Line Development Service Development of cell lines with gene knockdown for functional studies. Delivered to researchers requiring loss-of-function cellular models for target validation.
• Fluorescent Cell Line Development Service Development of fluorescently tagged cell lines for imaging and tracking studies. Delivered to researchers needing labeled cell lines for high-content imaging and tracking experiments.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered minor.

• Google LLCminorOthersGoogle provides analytics services to Innoprot through Google Analytics, collecting anonymous information about website visitors including number of visitors and popular pages. Data is stored on servers in the United States.
• Meta Platforms (Facebook)minorOthersMeta Platforms provides social media integration and marketing services. Social media plugins allow access to social networks from the Innoprot website, with associated cookies for tracking and marketing purposes.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Eurofins Discovery: Larger discovery services arm of Eurofins offering GPCR screening, cell-based assays, and custom cell line generation as part of a broader CRO portfolio. Comparable in service offering scope but with substantially greater scale, geographic reach, and enterprise pharma relationships.
• Charles River Laboratories: Large CRO providing cell-based assay services and custom cell line generation as part of an integrated drug discovery offering. Comparable in service overlap (assay development, custom lines) but operates at significantly larger scale with enterprise-grade pharma relationships.
• Promega: Established life-sciences reagent and assay platform provider with GPCR and cell signaling assay products. Comparable in cell-based GPCR assay products (e.g., cAMP GloSensor) but Promega operates at much larger scale with broader reagent and instrument portfolios.
• Corning Life Sciences: Major supplier of cell culture media, sera, and culture vessels used alongside cell-based assays. Comparable in the cell culture media/reagent add-on category, though Corning's scale and distribution network dwarf Innoprot's catalog.
• ATCC: Global biological resource center supplying authenticated cell lines, primary cells, and culture reagents. Comparable in primary cells and cell-line catalog offering, though ATCC's scope is broader (microbiology, genomics) and its scale and institutional credibility are materially larger.

Direct peers

• Cell Biolabs: Supplier of cell-based assay kits, cell lines, and reagents for signal transduction and drug discovery research. Comparable niche positioning in cell-based assay kits and reagents serving the same pharma/biotech/academic screening market.
• GenScript: Global biotech offering custom cell line development (stable, knockout, knock-in, overexpression) and cell-based assay services. Directly comparable in the custom cell-engineering services segment where Innoprot's immortalization, knockdown, and fluorescent line services compete.
• BPS Bioscience: San Diego-based supplier of recombinant cell lines, cell-based assay kits, and custom enzyme/cell line services for drug discovery. Closely comparable in product mix (stable cell lines, specialty assays, custom services) and target customer base (pharma/biotech screening).
• DiscoverX (Eurofins DiscoverX Products): Owned by Eurofins, DiscoverX is a leading provider of GPCR cell lines and cell-based assay platforms (PathHunter β-arrestin, HitHunter cAMP, GPCR Internalization assays). Most directly comparable competitor in Innoprot's core GPCR cell-line and assay-kit business.

Emerging players

• Cell Signaling Technology (CST): Specialized antibody/reagent company with growing cell-based assay offerings relevant to GPCR and signaling pathway research. Comparable in pathway-biology focus and pharma/biotech customer overlap, though CST's primary franchise is antibodies rather than engineered cell lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/innoprot

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innoprot